Under the microscope: Regeneus (ASX:RGS) - Iain Wilkie, Analyst

from Morgans Under the Microscope · host Morgans Financial Limited

Morgans Analyst Iain Wilkie talks to CEO of ASX listed regenerative medicine and stem-cell player Regeneus (ASX:RGS) on what the company does and a number of potential catalysts which lie ahead.

Episode metadata supplied by the publisher feed · Published Jun 25, 2020

Embed this episode

Attribution link and audio player

NOW PLAYING

Under the microscope: Regeneus (ASX:RGS) - Iain Wilkie, Analyst

0:00 10:55

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of Morgans Under the Microscope?

This episode is 10 minutes long.

When was this Morgans Under the Microscope episode published?

This episode was published on June 25, 2020.

Can I download this Morgans Under the Microscope episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!